drugset / Trial / NCT00671996

Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C

NCT00671996

Phase 2 Completed 14 enrolled Egetis Therapeutics
RandomizedParallel-groupSingle-blindTreatment

Summary

The present feasibility study is designed to find out whether pre-treatment with the compound mangafodipir lowers the frequency and severity of side effects during adjuvant chemotherapy according to the FOLFOX6 regimen in patients operated upon colon cancer in stage Dukes' C.

Timeline

Start
2008-06
Primary completion
2010-04
Completion
2010-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mangafodipir Diagnostic / imaging agent 2 unknown Intravenous

Indications